Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms

Fig. 1

Results are presented as Scatter dot: median with interquartile range. PCSK9 levels at baseline among TNF–α antagonist-treated patients with remission (DAS < 2.6) vs non-remission (DAS ≥ 2.6) after 1 year. Results are presented as whiskers: min to max. Student’s t test was performed for statistical analysisk

Back to article page